In a nutshell This study wanted to find out if shortening treatment for HER2-positive breast cancer with trastuzumab (Herceptin) from 1 year to 9 weeks would make the treatment less effective. The study found that treatment for nine weeks was not less effective than treatment for 1 year. Some background HER-2 positive breast cancer is a type of...
Read MoreBreast cancer Posts on Medivizor
How effective is myofascial release after breast cancer surgery?
In a nutshell This article investigated the safety and effectiveness of myofascial release (MR) therapy on women survivors of breast cancer. The authors concluded that MR therapy is safe and resulted in physical benefits (overall shoulder movement, functionality, pain). Some background Surgery and radiation are among the main treatments for...
Read MoreIntraoperative electron radiotherapy in treating breast cancer
In a nutshell This study wanted to find out what benefits there were to doing electron radiation therapy during surgery alongside normal radiation therapy for women with breast cancer. The study found that ten years after surgery, almost all the patients who had electron radiotherapy during surgery had no reoccurrence of breast cancer. Some...
Read MoreAdding ixabepilone to capecitabine treatment for triple negative breast cancer.
In a nutshell This study wanted to find out if ixabepilone (Ixempra) and capecitabine (Xeloda) work for treating triple-negative breast cancer in patients with hard to treat disease compared to using capecitabine alone. The study found that adding ixabepilone to treatment resulted in longer survival without the cancer progressing. Some background...
Read MoreJoint pain management in obese breast cancer patients treated with aromatase inhibitors
In a nutshell This article investigated the safety and effectiveness of adding Omega-3 fatty acid (O3-FA) to the management of joint pain in patients with breast cancer treated with aromatase inhibitors. The authors concluded that the addition of O3-FA is safe and gave the greatest benefit to patients who were obese. Some background...
Read MoreAdding pertuzumab to treatment in breast cancer
In a nutshell This study wanted to find out which treatment is better for breast cancer, chemotherapy plus trastuzumab (Herceptin) and surgery, or pertuzumab (Perjeta), and chemotherapy plus trastuzumab (Herceptin) and surgery. The study found that adding pertuzumab to the standard treatment worked better to completely remove all signs of cancer compared...
Read MoreTherapy for women with breast cancer experiencing depression
In a nutshell This paper was looking at which type of therapy is best for women with breast cancer who are experiencing major depression. The study found that all three therapies tested resulted in equal benefit for the patients. Some background It is well known that there is an association between being diagnosed with breast cancer and...
Read MoreAdding olanzapine to standard treatments to prevent nausea and vomiting in breast cancer chemotherapy
In a nutshell This study wanted to find out if adding a medication called olanzapine (Zyprexa) to the current treatment methods helps reduce vomiting and nausea in patients with breast cancer who are receiving chemotherapy with anthracycline. The study found that adding in olanzapine to standard treatment helped reduce vomiting and nausea compared to...
Read MoreAdding anthracyclines or carboplatin to standard treatment of breast cancer
In a nutshell This study wanted to find out which medication is better for treating HER-2 positive breast cancer, a class of medicines called anthracyclines plus trastuzmab (Herceptin) and pertuzmab (Perjeta), or carboplatin (Paraplatin) plus trastuzmab and pertuzmab. The study found that both medications worked equally as well as each other, but the...
Read MoreAtezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
In a nutshell This study wanted to see how well two medications worked in treating advanced triple negative breast cancer, atezolizumab (Tecentriq) and nab-paclitaxcel (Abraxane). The study found that using these two medications together improved survival in these patients. Some background Triple-negative breast cancer (TNBC) is breast cancer...
Read MoreScalp cooling to prevent hair loss in patients with breast cancer
In a nutshell This study wanted to see if using a scalp cooling cap during chemotherapy stopped patients with breast cancer from losing their hair. The study found that scalp cooling help prevent the patients from losing their hair. Some background An unfortunate side effect of chemotherapy for breast cancer is that often, patients lose their hair. It...
Read MoreBreast conserving surgery plus radiotherapy vs mastectomy in stage 1 breast cancer
In a nutshell This study wanted to find out which treatment was better for stage 1 breast cancer, either breast-conserving surgery plus radiotherapy, or mastectomy alone. The study found that breast conserving surgery plus radiotherapy was better than mastectomy for patients with stage 1 breast cancer. Some background There are a number of treatment...
Read More
